Zusammenfassung
Beim Hodgkin-Lymphom handelt es sich um maligne Neoplasien des lymphatischen Gewebes, bei der typischerweise Keimzentrum-B-Zellen im Lymphknoten entarten und in der Biopsie als multinukleäre Sternberg-Reed- oder einzellige Hodgkin-Riesenzellen nachgewiesen werden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Bhatia S, Robison LL, Oberlin O et al. (1996) Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N Engl J Med 334: 745–751
Brämswig JH, Heimes U, Heiermann E et al. (1990) The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin’s disease during childhood or adolescence. Cancer 65: 1298–1302
Dieckmann K, Potter R, Wagner W et al. (2002) Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin’s disease trial with 71 participating hospitals: the experience of the German-Austrian pediatric multicenter trial DAL-HD-90. Radiother Oncol 62: 191–200
Dorffel W, Albrecht M, Luders H et al. (1998) Multi-national therapy study for Hodgkin’s disease in children and adolescents GPOH-DH 95. Interim report after 2 1/2 years Klin Padiatr 210: 212–219
Gerres L, Bramswig JH, Schlegel W, Jurgens H, Schellong G (1998) The effects of etoposide on testicular function in boys treated for Hodgkin’s disease. Cancer 83:217–2222
Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D et al. (2007) Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 110: 179–185
Mauz-Körholz C, Hasenclever D, Dörffel W et al. (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study. J Clin Oncol 10: 3680–3686
Purz S, Mauz-Körholz C, Körholz D et al. (2011) Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin’s lymphoma. J Clin Oncol 29: 3523–3528
Schellong G, Bramswig J, Ludwig R et al. (1986) Combined treatment strategy in over 200 children with Hodgkin’s disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82. Klin Padiatr 198: 137–146
Schellong G, Hörnig I, Brämswig J et al. (1988) Zur Bedeutung des Procarbazins in der Chemotherapie des Morbus Hodgkin – Ein Bericht der kooperativen Therapiestudie DAL-HD-85. Klin Pädiatr 200: 205–213
Schellong G, Potter R, Bramswig J et al. (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin’s Disease Study Group. J Clin Oncol 17: 3736–3744
Schellong G, Riepenhausen M, Bruch C et al. (2010) Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer 55: 1145–1152
Trieu Y, Wen XY, Skinnider BF et al. (2004) Soluble interleukin 13 alpha-2 decoy receptor inhibits Hodgkin’s lymphoma growth in vitro and in vivo. Cancer Res 64: 3271–3275
Urayama KY, Jarrett RF, Hjalgrim H et al. (2012)Genome-wide association study of classical Hodgkin’s Lymphoma and Epstein-Barr Virus status-defined subgroups. J Natl. Cancer Institute 104: 240–253
Westergaard T, Melbye M, Pedersen JB et al. (1997) Birth order, sibship size and risk of Hodgkin’s disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 72: 977–981
Younes A, Bartlett NL, Leonard JP et al. (2010) Brentuximab vedotin (SGN-35) for relapsed CD30 positive Lymphomas. N Engl J Med 363: 1812–1821
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Körholz, D., Müller, C.M. (2014). Hodgkin-Lymphom. In: Reinhardt, D., Nicolai, T., Zimmer, KP. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41814-3_55
Download citation
DOI: https://doi.org/10.1007/978-3-642-41814-3_55
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41813-6
Online ISBN: 978-3-642-41814-3
eBook Packages: Medicine (German Language)